A football fan who has stage four prostate cancer is backing a campaign for sanitary bins to be put in men's toilets at ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms ...

Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

WebMD tells you about the causes and treatments of urinary incontinence in men. What Your Pee Can Tell You About Your Health Your pee -- you see it every day, and you might not think twice about it.

If you have urinary pain that lasts more than six weeks ... About 1.3% of American men or people assigned male at birth (AMAB) also have it. On average, people first start having problems in ...

The charity said that for the 475,000 men living with or after prostate cancer in the UK, many will experience urinary incontinence as a side effect of treatment for the disease. A UK-wide study ...

Roughly one in every three men over the age of 65 in the UK face urinary incontinence, according to the Prostate Cancer UK charity An athlete and a former semi-pro footballer says he has been "put ...

Urinary incontinence, defined as the involuntary loss of urine, is common, particularly in women. Despite its significant consequences, it is often under recognized and under treated. In one ...

Additionally, the average daily number of urge urinary incontinence episodes was lower ... of Gemtesa is an important milestone for the men with unresolved symptoms of OAB while being treated ...